BCP Investment Corp quarterly report, Q3 FY2022

Business context and reporting period

The supplied filing is Portman Ridge Finance Corporation’s unaudited Form 10-Q for the quarter ended September 30, 2022, not a filing identified as BCP Investment Corp. Portman Ridge is an externally managed business development company (BDC) investing primarily in debt and equity of middle-market companies.

Financial performance and position

Amounts below are in millions of dollars except per-share data and percentages. The nine-month comparison is year over year; balance-sheet comparisons are to December 31, 2021.

MetricQ3 2022Q3 2021Nine months 2022Nine months 2021
Investment income$19.0$22.9$51.0$62.8
Net investment income$8.4$13.7$21.8$33.6
Net increase (decrease) in net assets from operations$(4.2)$9.1$(8.6)$28.0
Operations per share$(0.44)$1.00$(0.89)$3.41
Net investment income per share$0.87$1.50$2.26$4.10
  • Investment-income margin: net investment income was about 44% of investment income in Q3 2022, versus 60% a year earlier; for the first nine months, about 43% versus 54%.
  • Cash flow: operating activities used $25.0 million in the first nine months, compared with $47.8 million provided in 2021. Cash and restricted cash totaled $39.1 million at September 30, down from $68.3 million at year-end.
  • Investments and NAV: investments at fair value were $571.7 million, up from $550.0 million at year-end. Net assets were $251.6 million, down from $280.1 million; NAV per share fell to $26.18 from $28.88.
  • Debt and liquidity: debt was $363.8 million net carrying value ($368.9 million par). Asset coverage was 167%, above the 150% statutory minimum. The company reported compliance with its debt covenants. Cash and restricted cash were $39.1 million; restricted cash accounted for $22.2 million.
  • Portfolio: fair value was $415.8 million in senior secured loans, $61.5 million in junior secured loans, $24.5 million in equity, $24.6 million in CLO securities and $45.1 million in joint ventures. Three debt investments were on non-accrual, versus seven at year-end 2021.

Material changes versus comparable periods

  • Nine-month investment income fell 19% and net investment income fell 35% year over year. Management attributed part of the reported income decline to lower purchase-discount accretion from the GARS and HCAP acquisitions; that accretion was $4.5 million versus $12.0 million. Excluding it, the company’s non-GAAP “core investment income” was $46.5 million versus $50.8 million.
  • Nine-month realized investment losses increased to $28.6 million from $11.4 million. The 2022 period also included a $1.1 million tax provision on realized and unrealized investment results.
  • Net unrealized depreciation was $0.7 million for the nine months, compared with $7.6 million of unrealized appreciation in 2021. Q3 operations turned to a $4.2 million loss from $9.1 million income a year earlier.
  • Debt interest and amortization expense rose to $11.9 million for nine months from $10.3 million; the weighted-average stated debt rate at quarter-end increased to 5.0% from 3.2% at year-end 2021.
  • Portfolio mix shifted toward senior secured loans, 73% of investment fair value versus 66% at year-end; joint ventures declined to 8% from 11%. The company invested about $174.9 million in portfolio companies during the first nine months.

Outlook, risks, contingencies and unusual items

  • No formal earnings or investment-income guidance was provided. The board declared a subsequent cash distribution of $0.67 per share, payable December 13, 2022 to holders of record November 24, 2022. The company stated it intends to continue quarterly distributions, subject to board decisions, taxable income and statutory and debt-agreement constraints.
  • Management’s stated strategy is to grow the portfolio through new capital and prudent leverage while maintaining liquidity. The filing also says the company was in the initial stages of evaluating a possible merger with one or more affiliated funds; terms and outcome were not established.
  • Interest-rate sensitivity analysis estimated annualized net investment income would increase about $2.1 million with a 1 percentage-point rate increase, and decrease about $0.6 million with a 2-point rate decrease. These estimates assume a constant balance sheet and do not reflect changes in credit quality or portfolio composition.
  • Key risks include below-investment-grade borrower credit risk, floating-rate exposure and funding costs, concentrated valuation uncertainty, illiquid and restricted investments, CLO leverage and potential distribution variability, and possible adverse economic or market conditions. Most portfolio assets are Level III, valued using significant unobservable inputs.
  • Unfunded investment commitments totaled $54.4 million, including a $21.7 million commitment to the Great Lakes II joint venture. The filing reports a putative stockholder lawsuit related to the HCAP merger; it is at an early stage, and the outcome and reasonably possible loss could not be estimated. Management did not expect ordinary-course litigation to materially affect the company overall.
  • Fair value remains a significant estimate. The portfolio’s aggregate cost exceeded fair value by about $58.5 million at quarter-end. Three debt investments were on non-accrual. No material subsequent event other than the declared distribution was disclosed.

Important facts for investors to verify

  • Confirm the issuer and ticker: the supplied filing is for Portman Ridge Finance Corporation (PTMN), despite the request metadata naming BCP Investment Corp.
  • Review the drivers and recoverability of the $28.6 million nine-month realized investment losses and the carrying values of material non-accrual and Level III positions.
  • Assess whether recurring cash income supports distributions, distinguishing cash receipts from PIK income, CLO accounting income and acquisition-related purchase-discount accretion.
  • Monitor leverage headroom, asset coverage, floating-rate debt costs, liquidity and the $54.4 million unfunded commitments.
  • Track the HCAP-related litigation and any developments in the potential affiliated-fund merger evaluation.